ONEMEDNET CORPORATION Cost of Revenue
ONEMEDNET CORPORATION (ONMD) reported Cost of Revenue of $857.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-14
- ONEMEDNET CORPORATION cost of revenue for the quarter ending 2026-06-30 was $857.00K, a 116.41% increase year-over-year.
- ONEMEDNET CORPORATION cost of revenue for the quarter ending 2026-03-31 was $476.00K, a 31.86% increase year-over-year.
- ONEMEDNET CORPORATION cost of revenue for the quarter ending 2025-12-31 was $726.00K, a 1296.15% increase year-over-year.
- ONEMEDNET CORPORATION cost of revenue for the quarter ending 2025-09-30 was $399.00K, a 76.55% increase year-over-year.
- ONEMEDNET CORPORATION cost of revenue for fiscal 2023 was $1.15M, a 23.99% decline from fiscal 2022.
- ONEMEDNET CORPORATION cost of revenue for fiscal 2022 was $1.51M.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $857.00K 10-Q · filed 2026-08-14 | $1.54M 10-Q · filed 2026-08-14 | $2.06M derived: sum of 3 quarters · filed 2026-08-14 | $2.46M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $476.00K S-1/A · filed 2026-07-08 | $1.20M derived: sum of 2 quarters · filed 2026-07-08 | $1.60M derived: sum of 3 quarters · filed 2026-07-08 | $2.00M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $726.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $1.13M derived: sum of 2 quarters · filed 2026-07-08 | $1.52M derived: sum of 3 quarters · filed 2026-08-14 | $1.86M S-1/A · filed 2026-07-08 | ||
| 2025-09-30 | $399.00K 10-Q · filed 2025-11-14 | $795.00K derived: sum of 2 quarters · filed 2026-08-14 | $1.14M 10-Q · filed 2025-11-14 | $1.21M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $396.00K 10-Q · filed 2026-08-14 | $737.00K 10-Q · filed 2026-08-14 | $809.00K derived: sum of 3 quarters · filed 2026-08-14 | $1.03M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $361.00K S-1/A · filed 2026-07-08 | $413.00K derived: sum of 2 quarters · filed 2026-07-08 | $639.00K derived: sum of 3 quarters · filed 2026-07-08 | $968.00K derived: sum of 4 quarters · filed 2026-07-08 | ||
| 2024-12-31 | $52.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $278.00K derived: sum of 2 quarters · filed 2026-07-08 | $607.00K derived: sum of 3 quarters · filed 2026-07-08 | $924.00K S-1/A · filed 2026-07-08 | ||
| 2024-09-30 | $226.00K 10-Q · filed 2025-11-14 | $555.00K derived: sum of 2 quarters · filed 2025-11-14 | $872.00K 10-Q · filed 2025-11-14 | $1.21M derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $329.00K 10-Q · filed 2025-08-13 | $646.00K 10-Q · filed 2025-08-13 | $984.00K derived: sum of 3 quarters · filed 2025-08-13 | $1.28M derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $317.00K 10-Q · filed 2025-05-14 | $655.00K derived: sum of 2 quarters · filed 2025-05-14 | $948.00K derived: sum of 3 quarters · filed 2025-05-14 | $1.18M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $338.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $631.00K derived: sum of 2 quarters · filed 2025-04-15 | $861.00K derived: sum of 3 quarters · filed 2025-04-15 | $1.15M 10-K · filed 2025-04-15 | $1.15M 10-K · filed 2024-04-09 | |
| 2023-09-30 | $293.00K 10-Q · filed 2024-12-17 | $523.00K derived: sum of 2 quarters · filed 2024-12-17 | $812.00K 10-Q · filed 2024-12-17 | $812.20K 10-Q · filed 2023-11-20 | $1.22M derived: sum of 4 quarters · filed 2024-12-17 | |
| 2023-06-30 | $230.00K 10-Q · filed 2024-12-11 | $519.00K 10-Q · filed 2024-12-11 | $926.00K derived: sum of 3 quarters · filed 2024-12-11 | $1.40M derived: sum of 4 quarters · filed 2024-12-11 | ||
| 2023-03-31 | $289.00K 10-Q · filed 2024-12-05 | $696.00K derived: sum of 2 quarters · filed 2024-12-05 | $1.17M derived: sum of 3 quarters · filed 2024-12-05 | |||
| 2022-12-31 | $407.00K derived: 10-K/A 12 month − 8-K/A 9 month · filed 2024-11-05 | $881.00K derived: sum of 2 quarters · filed 2024-11-22 | $1.51M 10-K/A · filed 2024-11-05 | $1.51M 10-K · filed 2024-04-09 | ||
| 2022-09-30 | $474.00K 8-K/A · filed 2024-11-22 | $1.11M 8-K/A · filed 2024-11-22 | $1.11M 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |